PMID: 6106508Sep 17, 1980Paper

Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP

Biochimica Et Biophysica Acta
M C RaoM Field

Abstract

Some enteric strains of Escherichia coli release a heat-stable enterotoxin which, in contrast to cholera and heat-labile E. coli enterotoxins, stimulates guanylate cyclase (GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2). We have examined the tissue spcificity of its action and the relation of its action to those of the 8-bromo analogues of cyclic GMP and cyclic AMP. Heat-stable enterotoxin stimulated guanylate cyclase activity and increased cyclic GMP concentration throughout the small and large intestine. It increased transepithelial electric potential difference and short-circuit current in the jejunum, ileum and caecum but not in the duodenum or distal colon. This pattern of electrical responses was mimicked by 8-bromo-cyclic GMP. However, 8-bromo-cyclic AMP produced an electrical response in all intestinal segments. The enterotoxin failed to stimulate guanylate cyclase inliver, lung, pancreas or gastric antral mucosa. In the intestines, it stimulated only the particulate and not the soluble form of the enzyme. Preincubation of the toxin with intestinal membranes did not render it capable of stimulating pancreatic guanylate cyclase. Cytosol factors did not enhance the toxin's stimulation of intestinal guanylate cyclase. Th...Continue Reading

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M FieldP L Smith
Jul 1, 1975·The American Journal of Physiology·M FieldP L Smith
Jun 1, 1979·Infection and Immunity·R A KapitanyR W Worthington
Oct 14, 1976·The New England Journal of Medicine·R W RyderF F Barrett
Sep 27, 1973·Biochimica Et Biophysica Acta·J SchmitzR K Crane
May 1, 1971·The American Journal of Physiology·M FieldI McColl

❮ Previous
Next ❯

Citations

Jan 1, 1990·Toxicon : Official Journal of the International Society on Toxinology·F C KnoopW J Boehm
Jan 1, 1991·Pharmacology & Therapeutics·D L Garbers
Dec 5, 1996·European Journal of Pharmacology·A Schirgi-Degen, E Beubler
Jan 12, 2000·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·A N CharneyR W Egnor
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·G M PitariS A Waldman
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·S L CarrithersS A Waldman
Mar 1, 1992·Pharmacology & Toxicology·A A LimaM C Fonteles
Apr 1, 1988·The Journal of Clinical Investigation·J H SellinE J Cragoe
Jun 27, 2012·Biomarkers in Medicine·Jian P GongScott A Waldman
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J Gariépy, G K Schoolnik
Nov 1, 1987·Archives internationales de physiologie et de biochimie·M Gilles-BaillienP Y Duchesne
Feb 24, 2016·Nature Reviews. Immunology·Araceli Perez-LopezManuela Raffatellu
Apr 30, 2016·Cellular and Molecular Gastroenterology and Hepatology·Onur CilA S Verkman
Jun 28, 1985·The American Journal of Medicine·J R Cantey
Mar 24, 2012·Journal of Surgical Oncology·Alex MejiaScott A Waldman
Sep 3, 2013·Current Opinion in Pharmacology·Jay R Thiagarajah, A S Verkman
Jul 1, 2015·Nature Reviews. Gastroenterology & Hepatology·Jay R ThiagarajahAlan S Verkman
Apr 16, 1998·Microbial Pathogenesis·G B Nair, Y Takeda
Feb 16, 2005·Annual Review of Physiology·John P Geibel
Nov 7, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Onur CilAlan S Verkman
Nov 10, 2009·Expert Review of Molecular Diagnostics·Alex MejiaScott A Waldman
Feb 14, 2008·Expert Opinion on Therapeutic Targets·Darren D Browning
Apr 1, 1990·Gastroenterology·A N Charney, H M Dansky
Jul 22, 1988·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·G T McEwanM L Lucas
Jan 12, 2007·American Journal of Physiology. Cell Physiology·Aliye UcJohn B Stokes
Jun 1, 1989·Archives of Disease in Childhood·A GuarinoS Guandalini
Sep 21, 1989·The New England Journal of Medicine·M FieldE B Chang
Feb 24, 2001·Annals of the New York Academy of Sciences·J VenkatasubramanianM C Rao
Aug 24, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·R TorianoM Parisi
Feb 24, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·A N CharneyR A Giannella
Feb 1, 1996·Diseases of the Colon and Rectum·S L CarrithersS A Waldman
May 1, 1990·The American Journal of Physiology·C ToskulkaoM C Rao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.